Connect to share and comment

Novartis replaces top Japan executives over drug trial scandal

PlacardEnlarge
(Globalpost/GlobalPost)

Swiss pharmaceutical giant Novartis said Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.

David Epstein, the head of the firm's pharmaceutical division, told a news briefing in Tokyo that the senior managers "resigned, they are out of the company", adding that "this kind of behaviour is unacceptable and a clear violation of our code of conduct".

kh-oh-pb/dan

http://www.globalpost.com/dispatch/news/afp/140403/novartis-replaces-top-japan-executives-over-drug-trial-scandal